Distribution of Rotavirus Genotypes After Introduction of Rotavirus Vaccines, Rotarix (R) and RotaTeq (R), into the National Immunization Program of Australia

Grants

Funding Acknowledgements

The work of the Australian Rotavirus Surveillance Program was supported by grants from the Australian Commonwealth Department of Health and Aging, GSK Biologicals (Melbourne, Australia) and Commonwealth Serum Laboratories (Melbourne, Australia). C.D. Kirkwood was supported by a CDA Research Fellowship from the National Health and Medical Research Council of Australia (607347). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. C.D.K.. G.L.B., and R.F.B. have received research grants from GlaxoSmithKline and Commonwealth Serum Laboratories.The authors thank all the collaborating laboratories for their effort in collecting and providing specimens. The Australian Rota virus Surveillance group includes the following members: R. Alexander, J. De Boer, C. Farrar, G. Harnett, A. Kesson, A. Lawrence, M Leung, K. Lindsay, M. Lyon, J. McLeod, C. McIver, F. Morey, M. Nissen, W. Rawlinson, H. Reed, D. Smith, P. South well, and B. Truscott. The Australian Rotavirus Surveillance program is supported by grants from the Australian Government Department of Health and Ageing, GlaxoSmithKline, and CSL. Dr Kirkwood is supported by a CDA Fellowship, NHMRC (607347).